Technology | September 26, 2012

ACC Certifies Lumedx for Software Interoperability Between Four Registries

Only vendor certified for automatic data cross-population between cath PCI registry, ACTION Registry-GWTG, ICD registry, and the new IMPACT registry

Lumedx Software American College of Cardiology

September 26, 2012—The American College of Cardiology (ACC) has certified Lumedx software as fully interoperable between four ACC NCDR registries. Lumedx, a leading provider of integrated cardiovascular imaging and information systems, is currently the only software vendor offering this level of interoperability.

“We believe that interoperability is the next step in a more seamless user experience and will provide institutions with an easy, efficient means of collecting data and participating in the NCDR. We are excited to certify Lumedx software with this new functionality,” said Senior Director of NCDR Registry Services Barbara Christensen, MSHA, RN.

Interoperability means that once Lumedx clients capture data for an ACC outcomes registry, common fields in the other registries are automatically populated. Cross-population of data is now automatic in Lumedx software for:

  • CathPCI Registry – for diagnostic cardiac catheterizations and percutaneous interventions
  • ACTION Registry-GWTG – for acute coronary syndrome patients
  • ICD Registry – for implantable cardioverter defibrillators and leads
  • IMPACT Registry – for pediatric and adult congenital treatment

“Our clients participate in multiple cardiac registries and quality improvement initiatives," said Katrina Craig Valvis, Lumedx registries manager. "They work every day to capture the information they need for clinical outcomes reporting—and this effort can take a considerable amount of time without a good system in place. Interoperability between the Lumedx registry modules enables hospitals to monitor standards of care more efficiently."

Automatic cross-population of common data across ACC NCDR registries helps cardiovascular service lines:

  • Enhance data integrity
  • Comply with ACC guidelines
  • Run reports internally
  • Monitor program performance
  • Improve outcomes

 

Registry interoperability is the latest in a suite of tools developed to help hospitals meet the growing demand for accessible data and straightforward national registry participation. These solutions enable easy data collection while providing hospitals with the access and flexibility they need to get the most out of their data.

For more information: www.lumedx.com/registry-interop.aspx

 

 

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
ScImage and Invia Partnership Announced
News | Cardiac PACS| September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Overlay Init